The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Canada generic drug market reached a value of US$ 6.4 Billion in 2020. Looking forward, IMARC Group expects the market to reach a value of US$ 7.0 Billion by 2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
The country represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in Canada.
The report entitled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.
Key Questions Answered in this Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at